[Federal Register Volume 77, Number 246 (Friday, December 21, 2012)]
[Notices]
[Page 75672]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-30774]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances, Notice of Registration, 
Halo Pharmaceutical, Inc.

    By Notice dated July 30, 2012, and published in the Federal 
Register on August 7, 2012, 77 FR 47114, Halo Pharmaceutical, Inc., 30 
North Jefferson Road, Whippany, New Jersey 07981, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Dihydromorphine (9145).....................  I
Hydromorphone (9150).......................  II
------------------------------------------------------------------------

    Dihydromorphine is an intermediate in the manufacture of 
Hydromorphone and is not for commercial distribution. The company plans 
to manufacture Hydromorphone HCL for sale to other manufacturers, and 
for the manufacture of other controlled substance dosage units for 
distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a), and determined that the registration 
of Halo Pharmaceutical, Inc., to manufacture the listed basic classes 
of controlled substances is consistent with the public interest at this 
time. DEA has investigated Halo Pharmaceutical, Inc., to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed.

     Dated: December 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-30774 Filed 12-20-12; 8:45 am]
BILLING CODE 4410-09-P